Adequan I.M Injection 5 Ml American Regent
Adequan i.m. is a veterinary injectable product for intramuscular use in horses. It contains Polysulfated Glycosaminoglycan (PSGAG) 500 mg/5 mL (100 mg/mL) and is used in the management of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.
Key Features
- Veterinary injectable for horses
- Contains Polysulfated Glycosaminoglycan (PSGAG)
- Strength: 500 mg/5 mL
- Concentration: 100 mg/mL
- For intramuscular administration
- Supports management of degenerative joint conditions
- Used for traumatic joint dysfunction
- Helps in cases associated with lameness
- Commonly used in performance and sport horses
- Supplied as single-dose vials
Main Benefits
- Supports joint health and function
- Helps manage joint degeneration
- Suitable for horses with joint-related lameness
- Useful in professional equine treatment programs
- Convenient injectable formulation
Product Details
Product Name: Adequan i.m.
Active Ingredient: Polysulfated Glycosaminoglycan (PSGAG)
Concentration: 100 mg/mL
Dose Vial: 5 mL
Target Species: Horses
Route: Intramuscular
Presentation: 7 single-dose vials
Professional Description
Adequan i.m. is an intramuscular PSGAG injection developed for horses with non-infectious degenerative or traumatic joint dysfunction. It is widely used in equine joint-care programs to support mobility and manage joint-related lameness under veterinary supervision.